Beneficial effects of combined therapy with lacidipine and candesartan in obese hypertensive patients

Author:

Ashcheulova Tatiana1,Gerasimchuk Nina1,Kovalyova Olga1,Honchar Oleksii1

Affiliation:

1. Kharkiv National Medic University, Nauky Ave., Kharkiv , Ukraine

Abstract

Abstract Introduction. Obesity is becoming one of the leading risk factors of coronary heart disease, hypertension, cerebrovascular disease. Despite the presence of a large number of antihypertensive agents and scientific substantiation of antihypertensive treatment principles it would be wrong to assume that the problem is completely solved. Development of endothelial dysfunction is one of the key pathogenic mechanisms in hypertension. This process is proven to have contributed by immune inflammation activation which is mediated by pro-inflammatory cytokines and oxidative stress. Aims. To investigate the additional benefits of the combined antihypertensive therapy with lacidipine and candesartan on the basis of studying their antioxidant properties, impact on endothelial function and pro-inflammatory cytokines activity in hypertensive patients with overweight and obesity. Methods. A combination of a calcium channel blocker and angiotensin receptor blocker (lacidipine 2 mg, 4 mg, and candesartan 4mg, 8mg, 16mg) was prescribed to 30 patients with essential hypertension of grades 1-3, 30 to 65 years old (mean age - 54.7 ± 5.8 years), who previously have not been receiving regular antihypertensive therapy. Results. During the course of combined antihypertensive therapy with lacidipine and candesartan, a significant reduction in i-NOS activity, TNF-α to its type I soluble receptor ratio (TNF- α/sTNF-αRI), and oxidative stress marker - 8-iso-PgF2α has been observed. Activity of e-NOS, levels of SOD and catalase, in contrast, have increased by the end of observation period. Conclusion. The improvement of endothelial function due to lower level of oxidative stress and a significant decrease of immune activation has been observed in hypertensive patients with overweight and obesity under the influence of combined antihypertensive therapy with lacidipine and candesartan.

Publisher

Walter de Gruyter GmbH

Reference28 articles.

1. 1. Ruilope Lm. Renal Function And Cardiovascular Risk In Hypertensive Patients. J Hypertension. 2005; 23(10): 1787-8.

2. 2. Dyer Ar., Elliott P., Stamler Sr., Stamler J. Body Mass Index And Association Of Sodium And Potassium With Blood Pressure In Lntersalt . Hypertension. 1994; 23:729-6.

3. 3. Nussinovitch U. The Heart In Rheumatic, Autoimmune And Inflammatory Disease Pathophysiology, Clinical Aspects And Therapeutic Approaches. Academic Press, 2017: 766.

4. 4. Kovalyova O., Belovol A., Zayika M. The Role Of Oxidative Stress In Cardiovascular Disease. J Academy Of Medical Sciences Of Ukraine. 2005; 11(4): 660-70.

5. 5. Kovalyova O., Ashcheulova T. Tumor Necrosis Factor-Α, Apoptosis In The Pathology Of Cardiovascular System. Original, Kharkiv, 2003: 95.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3